Mumbai, the nation , has emerged as a crucial global center for the production of Budesonide Active Pharmaceutical Ingredient (API), with CAS No. 51333-22-3. Several established organizations are concentrating on the synthesis and marketing of this critical corticocopyright. Various manufacturers